These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2935413)

  • 1. [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.
    Porceddu ML; Ongini E; Biggio G
    Eur J Pharmacol; 1985 Dec; 118(3):367-70. PubMed ID: 2935413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine.
    Porceddu ML; Giorgi O; Ongini E; Mele S; Biggio G
    Life Sci; 1986 Jul; 39(4):321-8. PubMed ID: 3526066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 dopamine receptors in the rat retina: effect of dark adaptation and chronic blockade by SCH 23390.
    Porceddu ML; De Montis G; Mele S; Ongini E; Biggio G
    Brain Res; 1987 Oct; 424(2):264-71. PubMed ID: 2960425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390.
    Hyttel J
    Neuropharmacology; 1984 Dec; 23(12A):1395-401. PubMed ID: 6152023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
    Andersen PH; Braestrup C
    J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor.
    Sidhu A; van Oene JC; Dandridge P; Kaiser C; Kebabian JW
    Eur J Pharmacol; 1986 Sep; 128(3):213-20. PubMed ID: 2947806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
    Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O; Parkinson D; Nielsen M
    Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
    Porceddu ML; Giorgi O; De Montis G; Mele S; Cocco L; Ongini E; Biggio G
    Life Sci; 1987 Aug; 41(6):697-706. PubMed ID: 2956472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]SCH 23390 identifies D-1 binding sites in rat striatum and other brain areas.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Pharm Pharmacol; 1986 Dec; 38(12):907-12. PubMed ID: 2880965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
    McGonigle P; Boyson SJ; Reuter S; Molinoff PB
    Synapse; 1989; 3(1):74-82. PubMed ID: 2521960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effect of dopamine blockers on evoked acetylcholine release in rat striatal slices: a classical D-2 antagonist response?
    Boireau A; Chambry J; Dubedat P; Farges G; Carruette AM; Zundel JL; Blanchard JC
    Eur J Pharmacol; 1986 Aug; 128(1-2):93-8. PubMed ID: 2875894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.
    Hatta Y; Hatta S; Saito T
    Psychopharmacology (Berl); 1993; 110(4):383-9. PubMed ID: 7870906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum.
    Andersen PH; Grønvald FC; Jansen JA
    Life Sci; 1985 Nov; 37(21):1971-83. PubMed ID: 2415793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.